Affordable Access

Access to the full text

MYO5B mutations in pheochromocytoma/paraganglioma promote cancer progression

Authors
  • Tomić, Tajana Tešan
  • Olausson, Josefin
  • Rehammar, Anna
  • Deland, Lily
  • Muth, Andreas
  • Ejeskär, Katarina
  • Nilsson, Staffan
  • Kristiansson, Erik
  • Wassén, Ola Nilsson
  • Abel, Frida
Publication Date
Jan 01, 2020
Identifiers
DOI: 10.1371/journal.pgen.1008803
OAI: oai:DiVA.org:his-18878
Source
DiVA - Academic Archive On-line
Keywords
Language
English
License
Green
External links

Abstract

Identification of additional cancer-associated genes and secondary mutations driving the metastatic progression in pheochromocytoma and paraganglioma (PPGL) is important for subtyping, and may provide optimization of therapeutic regimens. We recently reported novel recurrent nonsynonymous mutations in the MYO5B gene in metastatic PPGL. Here, we explored the functional impact of these MYO5B mutations, and analyzed MYO5B expression in primary PPGL tumor cases in relation to mutation status. Immunohistochemistry and mRNA expression analysis in 30 PPGL tumors revealed an increased MYO5B expression in metastatic compared to non-metastatic cases. In addition, subcellular localization of MYO5B protein was altered from cytoplasmic to membranous in some metastatic tumors, and the strongest and most abnormal expression pattern was observed in a paraganglioma harboring a somatic MYO5B:p.G1611S mutation. In addition to five previously discovered MYO5B mutations, the present study of 30 PPGL (8 previous and 22 new samples) also revealed two, and hence recurrent, mutations in the gene paralog MYO5A. The three MYO5B missense mutations with the highest prediction scores (p.L587P, p.G1611S and p.R1641C) were selected and functionally validated using site directed mutagenesis and stable transfection into human neuroblastoma cells (SK-N-AS) and embryonic kidney cells (HEK293). In vitro analysis showed a significant increased proliferation rate in all three MYO5B mutated clones. The two somatically derived mutations, p.L587P and p.G1611S, were also found to increase the migration rate. Expression analysis of MYO5B mutants compared to wild type clones, demonstrated a significant enrichment of genes involved in migration, proliferation, cell adhesion, glucose metabolism, and cellular homeostasis. Our study validates the functional role of novel MYO5B mutations in proliferation and migration, and suggest the MYO5-pathway to be involved in the malignant progression in some PPGL tumors. © 2020 Tomic et al. / <p>Export Date: 6 August 2020; Article</p>

Report this publication

Statistics

Seen <100 times